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Abstract
Summary: Large-scale human genetics studies are now employing whole genome sequencing
with the goal of conducting comprehensive trait mapping analyses of all forms of genome variation. However, methods for structural variation (SV) analysis have lagged far behind those for
smaller scale variants, and there is an urgent need to develop more efficient tools that scale to the
size of human populations. Here, we present a fast and highly scalable software toolkit (svtools)
and cloud-based pipeline for assembling high quality SV maps—including deletions, duplications,
mobile element insertions, inversions and other rearrangements—in many thousands of human
genomes. We show that this pipeline achieves similar variant detection performance to established
per-sample methods (e.g. LUMPY), while providing fast and affordable joint analysis at the scale of
100 000 genomes. These tools will help enable the next generation of human genetics studies.
Availability and implementation: svtools is implemented in Python and freely available (MIT) from
https://github.com/hall-lab/svtools.
Contact: ihall@wustl.edu
Supplementary information: Supplementary data are available at Bioinformatics online.

1 Introduction
With the dramatic cost reduction of whole genome sequencing
(WGS) in recent years, large-scale human genetics studies are underway that aim to conduct comprehensive trait association analyses in
tens to hundreds of thousands of deeply sequenced (>20) individuals. Foremost among these are NIH programs such as NHGRI’s
Centers for Common Disease Genomics (CCDG) and NHLBI’s
Trans-Omics for Precision Medicine (TOPMed), which have generated >150 000 deep WGS datasets thus far. Moreover, ongoing
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genome aggregation efforts seek to produce even larger genome variation maps that can be mined for insights into genome biology, and
to help interpret personal genomes and rare disease studies. These
efforts, along with many others around the world, will usher in a
new era of data-centric human genetics research.
A key promise of WGS is the potential to assess all forms of genome variation. However, despite considerable effort and creativity
by many groups [most notably the 1000 Genomes Project, 1KGP
(Mills et al., 2011; Sudmant et al., 2015)], it remains extremely
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2 Materials and methods
We developed a software toolkit and distributed workflow for largescale SV callset generation that combines per-sample variant

discovery, resolution-aware cross-sample merging, breakpoint genotyping, copy number annotation, variant classification and callset
refinement (Fig. 1). We release the svtools python toolkit (https://
github.com/hall-lab/svtools) and two pipeline versions: an onpremises ‘B37’ version designed to handle BAM files aligned to the
GRCh37 reference genome, that relies mainly on BASH scripts and
LSF commands; and a cloud-based ‘B38’ pipeline written in WDL
designed to work with CRAM (Hsi-Yang Fritz et al., 2011) files
aligned to GRCh38 using the new ‘functional equivalence’ standard
developed by the CCDG and TOPMed programs (Regier et al.,
2018). Despite their different workflow implementations and reference genome versions, the core tools and parameters are virtually
identical between these two pipelines, and both are publicly available (https://github.com/hall-lab/sv-pipeline).
The first step is to analyze each genome separately, in parallel.
We generate per-sample breakpoints calls using the LUMPY algorithm (Layer et al., 2014), which combines RP and SR alignment signals in a probabilistic breakpoint detection framework. LUMPY is a
widely used tool that has been benchmarked extensively in prior
studies (Chiang et al., 2015; Chiang et al., 2017; Layer et al., 2014);
here, we adapted LUMPY to CRAM and improved performance on
GRCh38 by masking highly repetitive and misassembled genomic
regions. The second step is to merge all candidate variants from all
samples into a single non-redundant VCF/BEDPE (Danecek et al.,
2011; Quinlan and Hall, 2010) file. Positional uncertainty is modeled during the merging process through the use of breakpoint probability distributions [as within LUMPY itself (Layer et al., 2014)],
which is possible because we have modified LUMPY to report the
integrated per-base probability distribution for each breakpointcontaining confidence interval in the output per-sample VCF. The
merging algorithm defines collections of SV predictions with mutually consistent coordinate intervals and orientations, as defined by
the extent of overlap between breakpoint probability distributions
in each sample, then combines and refines coordinates based on the
weight of alignment evidence at each base, in each sample.
We then genotype all candidate SV breakpoints in all samples
using SVTyper (Chiang et al., 2015). This tool measures RP, SR and
CR alignment signals at predicted breakpoints, in a more sensitive
and accurate manner than feasible with genome-wide SV discovery
tools such as LUMPY. The new svtools implementation handles
CRAM and is significantly faster and more sensitive than the original (Chiang et al., 2015). Quantitative allele balance information is
retained throughout the workflow to preserve trait mapping power
at difficult-to-genotype variants. Since certain CNVs are easier to
genotype by RD analysis than breakpoint-spanning alignments, we
also use CNVnator’s ‘genotype’ tool (Abyzov et al., 2011) to estimate the copy number of each SV interval in each sample. This copy
number information can be used in lieu of breakpoint genotypes as
desired in downstream association analyses and is crucial for SV
classification.
We next use a combination of breakpoint coordinates, breakpoint genotypes, read-depth evidence and genome annotations to
classify each SV breakpoint either as a deletion (DEL), duplication
(DUP), inversion (INV), mobile element insertion (MEI) or generic
rearrangement of unknown architecture (‘break-end’, BND) (see
Supplementary Methods for details). This is an important and challenging step. The main difficulty arises because breakpoint prediction tools such as LUMPY are designed to detect novel DNA
adjacencies, however, it is impossible to infer SV architecture from
such evidence alone. For example, DEL and MEI variants often have
identical breakpoint configurations (i.e. direct orientation), and
complex rearrangements are often defined by multiple adjacent
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difficult to assemble high quality structural variation (SV) maps
from WGS data, especially for large cohorts comprising thousands
of individuals. An initial obstacle is that SV detection is a difficult
problem even for small-scale studies due to fundamental limitations
in the integrity of short-read alignment signals used to infer breakpoint positions and estimate copy number from Illumina WGS data.
These alignment signals—including split-read (SR), clipped-read
(CR), read-pair (RP) and read-depth (RD)—are difficult to distinguish from sequencing and alignment artifacts, and are difficult to
integrate with each other, such that even the best performing tools
generally suffer from low sensitivity, high false discovery rates
(FDR) and high compute costs.
A second issue is that current WGS-based multi-sample variant
detection approaches require ‘joint’ analysis of raw (or nearly raw)
alignment data for each sample, at each putative variant site; however, due to memory and compute limitations, native joint calling
algorithms do not perform well beyond the scale of several hundred
genomes. SNV/indel detection tools such as GATK and VT have
implemented distributed workflows to distill and combine variant
detection signals in large cohorts through the use of intermediate
files (e.g. gVCF) and parallel ‘scatter-gather’ computing schemes. A
natural goal is to develop similar approaches for SVs.
However, for SV the problem is different and arguably much
harder. Tools must tolerate higher error rates and accommodate diverse variant sizes and architectures including balanced, complex and/
or repetitive variants that may be difficult to classify. Parallelization
schemes are complicated by the fact that, unlike SNVs that map to a
single coordinate, SV breakpoints are defined by pairs of discontiguous
and potentially distant strand-oriented reference genome coordinates.
Intermediate data structures analogous to gVCF are difficult to design
because they must encapsulate information from at least four disparate
alignment signals (SR, CR, RP, RD), each with different resolution and
artifact modalities. Cross-sample merging schemes must be robust to
positional uncertainty because SV breakpoint mapping resolution is
typically imprecise on a per-sample basis (10–100 bp mean), and
sequencing and alignment effects can vary widely across variant classes,
samples and batches. New approaches are required.
Of course, the task of combining spatially imprecise SV/CNV calls
across collections of samples is an old problem that has been dealt with
effectively through ad hoc methods in prior microarray (Conrad et al.,
2009; Redon et al., 2006; Wellcome Trust Case Control et al., 2010)
and WGS-based (Mills et al., 2011; Sudmant et al., 2015) studies.
However, array-based methods do not readily extend to balanced SVs
or to the increased resolution, complexity and scale of deep WGS.
1KGP employed a clever approach to merge results from multiple algorithms and platforms (Mills et al., 2011; Sudmant et al., 2015), but this
was a monumental effort and the methods therein are impractical for
routine use. GenomeSTRiP has two published workflows for detecting
SV in populations of samples, but both have limitations: an early version focuses on deletions and serially combines RP-based detection
with RD genotyping (Handsaker et al., 2011); a second RD-based
CNV pipeline is computationally expensive, low resolution (>1 kb),
and limited to moderate sample sizes (<1000) (Handsaker et al.,
2015). To our knowledge, no publicly available tools or reproducible
workflows exist to systematically assemble high-resolution SV callsets
from joint analysis of multiple alignment signals in tens of thousands of
deep WGS datasets, as we present here.
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Fig. 1. The svtools pipeline. SVs are detected separately in each sample using LUMPY. Breakpoint probability distributions are utilized to merge and refine the
coordinates of SV breakpoints within a cohort, followed by parallelized re-genotyping and copy number annotation. Variants are merged into a single cohort-level
VCF file and variant types are classified using the combined breakpoint genotype and read-depth information

breakpoints that masquerade as simple SVs. The ‘svtools classify’
tool distinguishes DELs and DUPs from balanced SVs (BNDs) based
on linear regression of quantitative breakpoint genotype information and copy number estimates from the affected genomic interval.

MEIs are discerned by the location of mobile elements in the reference genome, and inversions by the co-detection of two breakpoints
with inverted orientation. This classification step enables more
informed SV impact prediction (Ganel et al., 2017) and thus
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3 Results and discussion
The sensitivity, accuracy and utility of the core SV discovery and
genotyping algorithms in our pipeline have been thoroughly documented in multiple prior small-scale studies (Chiang et al., 2015;
Chiang et al., 2017; Layer et al., 2014). Here, we focus on the question of whether we achieve similar performance using the distributed
workflow on much larger sample sizes. We constructed two separate
callsets using identical methods: a ‘small’ 12-sample callset composed solely of 1KGP samples, and a ‘large’ 1000-sample callset
composed of the same 1KGP samples plus 988 Finnish samples.
We first assessed the relative sensitivity obtained in the small versus large callset using 1KGP calls as ground truth (Table 1).
We achieved nearly identical sensitivity levels in per-sample calls
prior to and after merging, at levels that are consistent with prior
single-sample tests (Chiang et al., 2015; Layer et al., 2014). This demonstrates the effectiveness of our cross-sample merging strategy.
Notably, sensitivity in both the small and large callsets improves markedly after the re-genotyping step. This demonstrates the benefits of
Table 1. Detection sensitivity in large and small cohorts
12 sample callset

Sample

HG00513
HG00731
HG00732
NA12878
NA19238
NA19239

Merge only

Reclassified (naı̈ve bayes)

Sensitivity
(all) (%)

Sensitivity
(all) (%)

80.94
78.17
82.40
82.39
84.39
74.39

Sensitivity
(HC) (%)

87.53
83.96
87.43
88.19
88.58
77.60

82.43
78.88
81.39
83.15
82.41
73.36

1000 sample callset

Sample

HG00513
HG00731
HG00732
NA12878
NA19238
NA19239

Merge only

Reclassified (regression)

Sensitivity
(all) (%)

Sensitivity
(all) (%)

80.23
77.67
81.50
81.58
83.86
74.01

88.03
84.47
88.12
88.62
88.53
77.81

Sensitivity
(HC) (%)
83.80
80.46
82.56
84.18
82.80
73.31

Note: Sensitivity is defined as percent of detectable 1000 Genomes Project
variants identified in the cohort. HC stands for high confidence variants.

re-genotyping, which is designed to be more sensitive than the initial
SV discovery step and—when combined with high resolution crosssample merging—emulates joint analysis by allowing evidence to be
borrowed across samples. This important feature also provides quality
and genotyping information for every sample, enabling confidence filtering of the variants. Taken together, this results in the uniform SV
levels apparent in a 8438-sample callset [generated for a different study
(Abel et al., 2018)] after re-genotyping and quality filtering, as compared to directly after calling (Supplementary Fig. S1). Sensitivity levels
after re-genotyping are similar in the large versus small callset, which
shows that our tools achieve comparable sensitivity at vastly different
sample sizes. As expected, sensitivity increases as a function of variant
allele frequency (Supplementary Fig. S3), which reflects the benefits of
joint analysis across samples with shared alleles. Note that these comparisons underestimate sensitivity given known false positives in 1KGP
(Chiang et al., 2015; Chiang et al., 2017; Layer et al., 2014).
Although it is impossible to measure FDR in the absence of a
comprehensive truth-set, Mendelian error (ME) rates serve as an informative proxy. To estimate ME, we examined inheritance patterns
in four separate parent-offspring trios included in the 12-sample and
1000-sample callsets (Table 2).
ME rates are high (12–17%) prior to re-genotyping, classification
and confidence scoring, but fall to acceptable levels (2–3%) for highconfidence calls in the final small and large callsets. The slightly higher
ME rate in the large callset is accompanied by substantially more variant calls and thus can be tuned to the desired ME rate depending of the
application-specific desired balance between sensitivity and specificity.
Consistent with these results, the significantly larger callsets we
have generated for other studies—based on 8417 samples (on premises B37 pipeline) and 23 559 samples (cloud-based B38 pipeline)—
exhibit similar numbers and types of variants (Supplementary Fig.
S1) and achieve similarly low ME rates (Abel et al., 2018). Taken together, these analyses demonstrate that our pipeline achieves high
performance at large sample sizes.
A key strength of our pipeline is scalability and cost. Tool performance metrics are provided from sets of 10, 100 and 1000 deep
(>20) genomes in Table 3.
Overall, most steps are efficient and require modest compute
resources, allowing them to be run on affordable cloud instances. For
the 1000 sample dataset used above, we estimate costs to be merely
$0.30 per dataset. The initial per-sample SV discovery steps have
been optimized for speed and cost ($0.13 per genome) and scale linearly with the number of samples. Merging is a complex and computeintensive process that can require significant RAM usage but is only necessary once per callset and can be parallelized. The current merging
strategy is effective with as many as 7000 samples, using commodity
hardware; however, for callsets exceeding several thousand samples we
recommend a tiered scheme, whereby separate batches of data (e.g.
1000 samples) are combined during an initial sample-level merging
step, followed by batch-level merging. Initial evidence suggests this approach results in similar if not higher quality breakpoint predictions
than bulk merging (Supplementary Fig. S2), especially if data are
batched by cohort and sequencing protocol.
The distributed genotyping step is the key bottleneck for large studies, since sensitive SV genotyping requires computationally expensive interrogation of raw alignment data, and aggregate compute time scales
as a function of both sample size and the number of candidate variants.
The latter is determined by a combination of sample size, ancestry composition, genetic relatedness and per-sample variant discovery FDR, and
is difficult to predict. Empirically, genotyping accounts for 6, 12 and
24% of compute at the scale of 10, 100 and 1000 genomes, respectively
(Table 3), and 78% of compute at the scale of 23 559 genomes.
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improves prioritization of rare SVs for human genetics studies. We
note that additional SV classes—including interspersed duplications,
retrogene insertions, translocations and complex rearrangements—
can be identified by further interrogation of BND calls, but that
rigorous automation of this process will require further work.
The final steps are callset refinement, tuning and quality control
(QC). These are extremely important for obtaining high quality
results, and ideally should take place with knowledge of genealogical relationships and SNVs. Miscellaneous tools are provided for allele frequency annotation, genotype refinement, confidence scoring,
cross-callset variant look-ups, variant pruning and file format conversion (see https://github.com/hall-lab/svtools#usage).
Additional details are available in the Supplementary Methods.
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Table 2. ME rate in large and small cohorts
12 sample

Family
CEPH1463
PR05
SH032
Y117

Merge only

Reclassified (naı̈ve bayes)

All

All

High confidence

Variants

ME rate (%)

Variants

ME rate (%)

Variants

ME rate (%)

6107
5783
5670
7534

12.72
15.75
16.83
15.18

6237
6182
6054
7519

8.11
8.57
8.77
8.83

3184
3164
3182
3889

2.29
2.24
2.64
2.24

Family
CEPH1463
PR05
SH032
Y117

Merge only

Reclassified (regression)

All

All

High confidence

Variants

ME rate (%)

Variants

ME rate (%)

Variants

ME rate (%)

6147
5827
5708
7568

12.93
15.99
16.92
15.38

10 429
10 381
10 123
11 488

13.13
14.54
14.29
13.34

3605
3629
3574
4208

2.77
2.98
3.33
2.69

Note: ME rate is defined as the number of MEs divided by the total number of informative variants on the autosomes.

Table 3. Computational benchmarking of svtools subcommands
Num. samples

10

Program

Wall (m)

RAM (MB)

Wall (m)

RAM (MB)

Wall (m)

RAM (MB)

0.129
2.108
13.425
0.225
0.088
0.096
0.083
0.079
0.179
0.079
0.033
6.938

5.964
87.791
2008.828
NA
NA
NA
NA
17.363
18.790
17.368
NA
530.722

1.117
18.708
31.725
0.333
1.379
0.908
0.183
0.183
0.404
0.183
0.100
8.250

1696.008
258.402
1222.536
NA
75.660
77.701
3.277
NA
61.667
34.794
0.594
526.480

16.788
193.346
61.413
0.533
79.083
20.192
0.933
0.892
1.388
0.879
1.508
25.621

3402.480
2032.114
1255.593
NA
181.845
97.713
70.851
70.904
171.728
71.003
900.887
680.900

lsort
lmerge
genotype
copynumber
vcfpaste
afreq
vcftobedpe
bedpesort
prune
bedpetovcf
vcfsort
classify

100

1000

Note: For three different size cohorts, each tool was run (n ¼ 4; n ¼ 3 for the 100 sample bedpetovcf) to generate mean wall clock time and RAM utilization. For
the genotype and copynumber commands, benchmarking was performed on a single, representative sample within the cohort of median file size. All other commands
were evaluated on the entire dataset. Some benchmarking runs finished before LSF was able to gather memory usage metrics and these are reported as NA.

Remarkably, a 23 559 genome callset for the study described in
Abel et al. (2018) was assembled on the Google Cloud at an empirical cost of $0.68 per sample. Based on the observed performance at
different scales, we expect our current pipeline to achieve affordable
callset generation (<$2 per sample) at the scale of 105 genomes, although improved methods may be necessary beyond that.
The tools described here will enable efficient and affordable
analyses of SV in population-scale WGS studies, furthering our
understanding of SV biology and enabling a more complete understanding of the contribution of SV to human traits.

the users of the svtools package for bug reports, questions and suggestions
that have greatly improved the software over time.
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